Amicus Therapeutics
FOLD
FOLD
141 hedge funds and large institutions have $1.75B invested in Amicus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% more funds holding
Funds holding: 134 → 141 (+7)
3.61% more ownership
Funds ownership: 118.25% → 121.86% (+3.6%)
0% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 44
Holders
141
Holding in Top 10
9
Calls
$31.4M
Puts
$12.9M
Top Buyers
| 1 | +$70.8M | |
| 2 | +$30.2M | |
| 3 | +$14.3M | |
| 4 |
Morgan Stanley
New York
|
+$11.3M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
+$11M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$10.4M | |
| 3 | -$10.3M | |
| 4 |
Axa
Paris,
France
|
-$8.47M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.34M |